Personalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Personalis, Inc. has been given a consensus recommendation of "Moderate Buy" by six analysts, with one sell and five buy ratings, and an average price target of $7.42.
• Institutional investors hold approximately 61.91% of the company's stock, with significant recent acquisitions from firms like BNP Paribas Financial Markets, which increased its position by 406.4%.
• In its latest earnings report, Personalis reported a net loss of ($0.23) per share for the quarter, exceeding estimates by $0.02, but revenue fell short of expectations at $17.20 million.

Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $7.4167.

PSNL has been the topic of several research reports. HC Wainwright reiterated a "buy" rating and set a $8.50 price target on shares of Personalis in a research report on Monday, September 8th. BTIG Research set a $6.00 price target on shares of Personalis in a research report on Wednesday, August 6th. Wall Street Zen upgraded shares of Personalis from a "sell" rating to a "hold" rating in a research report on Saturday, September 20th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Personalis in a research report on Wednesday.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Legal & General Group Plc acquired a new position in Personalis during the 2nd quarter valued at about $30,000. Ameritas Investment Partners Inc. acquired a new position in Personalis during the 2nd quarter valued at about $34,000. BNP Paribas Financial Markets lifted its position in Personalis by 406.4% during the 2nd quarter. BNP Paribas Financial Markets now owns 6,451 shares of the company's stock valued at $42,000 after purchasing an additional 5,177 shares during the period. Alpha Wealth Funds LLC acquired a new position in Personalis during the 2nd quarter valued at about $66,000. Finally, Police & Firemen s Retirement System of New Jersey acquired a new position in Personalis during the 2nd quarter valued at about $75,000. Institutional investors and hedge funds own 61.91% of the company's stock.

Personalis Stock Performance

PSNL opened at $8.12 on Friday. The firm's 50-day simple moving average is $5.64 and its 200-day simple moving average is $5.26. Personalis has a twelve month low of $2.83 and a twelve month high of $8.85. The firm has a market cap of $720.08 million, a price-to-earnings ratio of -6.34 and a beta of 1.83.

Personalis (NASDAQ:PSNL - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.02. The business had revenue of $17.20 million for the quarter, compared to analyst estimates of $20.12 million. Personalis had a negative net margin of 113.70% and a negative return on equity of 47.57%. Personalis has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts anticipate that Personalis will post -1.4 EPS for the current fiscal year.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.